BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23083102)

  • 1. Shigella flexneri T3SS effector IpaH4.5 modulates the host inflammatory response via interaction with NF-κB p65 protein.
    Wang F; Jiang Z; Li Y; He X; Zhao J; Yang X; Zhu L; Yin Z; Li X; Wang X; Liu W; Shang W; Yang Z; Wang S; Zhen Q; Zhang Z; Yu Y; Zhong H; Ye Q; Huang L; Yuan J
    Cell Microbiol; 2013 Mar; 15(3):474-85. PubMed ID: 23083102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shigella effector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation.
    Otsubo R; Mimuro H; Ashida H; Hamazaki J; Murata S; Sasakawa C
    Cell Microbiol; 2019 Mar; 21(3):e12974. PubMed ID: 30414351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shigella chromosomal IpaH proteins are secreted via the type III secretion system and act as effectors.
    Ashida H; Toyotome T; Nagai T; Sasakawa C
    Mol Microbiol; 2007 Feb; 63(3):680-93. PubMed ID: 17214743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
    Newton HJ; Pearson JS; Badea L; Kelly M; Lucas M; Holloway G; Wagstaff KM; Dunstone MA; Sloan J; Whisstock JC; Kaper JB; Robins-Browne RM; Jans DA; Frankel G; Phillips AD; Coulson BS; Hartland EL
    PLoS Pathog; 2010 May; 6(5):e1000898. PubMed ID: 20485572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial E3 Ubiquitin Ligase IpaH4.5 of Shigella flexneri Targets TBK1 To Dampen the Host Antibacterial Response.
    Zheng Z; Wei C; Guan K; Yuan Y; Zhang Y; Ma S; Cao Y; Wang F; Zhong H; He X
    J Immunol; 2016 Feb; 196(3):1199-208. PubMed ID: 26700764
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Sun J; Wang X; Lin H; Wan L; Chen J; Yang X; Li D; Zhang Y; He X; Wang B; Dong M; Zhong H; Wei C
    J Med Microbiol; 2021 Jul; 70(7):. PubMed ID: 34296983
    [No Abstract]   [Full Text] [Related]  

  • 7. The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection.
    Kobayashi T; Ogawa M; Sanada T; Mimuro H; Kim M; Ashida H; Akakura R; Yoshida M; Kawalec M; Reichhart JM; Mizushima T; Sasakawa C
    Cell Host Microbe; 2013 May; 13(5):570-583. PubMed ID: 23684308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria.
    Ashida H; Sasakawa C
    Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and utility of innate immune system evasion mechanisms of ASFV.
    Correia S; Ventura S; Parkhouse RM
    Virus Res; 2013 Apr; 173(1):87-100. PubMed ID: 23165138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes.
    Kim DW; Lenzen G; Page AL; Legrain P; Sansonetti PJ; Parsot C
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):14046-51. PubMed ID: 16162672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ShiA abrogates the innate T-cell response to Shigella flexneri infection.
    Ingersoll MA; Zychlinsky A
    Infect Immun; 2006 Apr; 74(4):2317-27. PubMed ID: 16552062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shigella flexneri type III secreted effector OspF reveals new crosstalks of proinflammatory signaling pathways during bacterial infection.
    Reiterer V; Grossniklaus L; Tschon T; Kasper CA; Sorg I; Arrieumerlou C
    Cell Signal; 2011 Jul; 23(7):1188-96. PubMed ID: 21402152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response.
    Sanada T; Kim M; Mimuro H; Suzuki M; Ogawa M; Oyama A; Ashida H; Kobayashi T; Koyama T; Nagai S; Shibata Y; Gohda J; Inoue J; Mizushima T; Sasakawa C
    Nature; 2012 Mar; 483(7391):623-6. PubMed ID: 22407319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of the virulence factor IpaB in Shigella spp. in the escape from immune cells and invasion of epithelial cells.
    Yang SC; Hung CF; Aljuffali IA; Fang JY
    Microbiol Res; 2015 Dec; 181():43-51. PubMed ID: 26640051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IpgB1 and IpgB2, two homologous effectors secreted via the Mxi-Spa type III secretion apparatus, cooperate to mediate polarized cell invasion and inflammatory potential of Shigella flexenri.
    Hachani A; Biskri L; Rossi G; Marty A; Ménard R; Sansonetti P; Parsot C; Van Nhieu GT; Bernardini ML; Allaoui A
    Microbes Infect; 2008 Mar; 10(3):260-8. PubMed ID: 18316224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Cellular Mechanisms of Shigella flexneri Dissemination.
    Agaisse H
    Front Cell Infect Microbiol; 2016; 6():29. PubMed ID: 27014639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence.
    Zurawski DV; Mitsuhata C; Mumy KL; McCormick BA; Maurelli AT
    Infect Immun; 2006 Oct; 74(10):5964-76. PubMed ID: 16988276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of pic results in decreased virulence for a clinical isolate of Shigella flexneri 2a from China.
    Zhang J; Qian L; Wu Y; Cai X; Li X; Cheng X; Qu D
    BMC Microbiol; 2013 Feb; 13():31. PubMed ID: 23391153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Nuclear Transport of NF-ĸB p65 by the Salmonella Type III Secretion System Effector SpvD.
    Rolhion N; Furniss RC; Grabe G; Ryan A; Liu M; Matthews SA; Holden DW
    PLoS Pathog; 2016 May; 12(5):e1005653. PubMed ID: 27232334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-kappaB p50 and p65.
    Wieland GD; Nehmann N; Müller D; Eibel H; Siebenlist U; Sühnel J; Zipfel PF; Skerka C
    J Cell Sci; 2005 Jul; 118(Pt 14):3203-12. PubMed ID: 16014385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.